Fiji Kava Convertible Notes
Brisbane, May 3, 2022 AEST (ABN Newswire) - Fiji Kava Ltd (
ASX:FIJ), is a health and wellness company with operations in Australia, Fiji, and the USA. The company which produces natural products to reduce anxiety, promote relaxation, improve sleep, and support sports recovery has raised $745,000 through the issue of convertible notes securities.
Fiji Kava CEO, Dr Anthony Noble said: "As the company ramps up entry activities for Kava products into the USA Market and expands distribution of beverage formats in Australia, Fiji and the USA, we are preparing for an uptick in demand for our drinking kava and CBD tincture products. New Australia and USA retail channels will require additional inventory and marketing investments to pipeline fill and support trade spend and marketing programs over the coming 5-18 months. The note structure of this capital raise reflects this timeline while providing us with the required funding for these important growth drivers in Australia and the USA."
*To view key terms, please visit:
https://abnnewswire.net/lnk/0653304O
About Fiji Kava Limited
Fiji Kava Limited (ASX: FIJ) is an Australian-Fijian medicinal kava health & wellness company, producing natural 'noble kava' products for the complementary and alternative medicine market, estimated to exceed USD $210 billion by 2026 globally. As the first foreign company with approval from the Fijian Government to operate in the kava industry, FijiKava has established a global leading sustainable and 100% traceable, certified organic supply chain of 'noble kava' including a nucleus farm in Levuka, on the island of Ovalau, Fiji.
FijiKava is focused on expanding the availability of noble kava products throughout western markets to provide a natural alternative to prescription medicines to promote sleep, soothe and calm the nerves, support muscle relaxation and relax the mind.
| ||
|
